CVS down 4% following presentation at Morgan Stanley investors conference

[CVS Pharmacy logo on their store in Las Vegas, USA. CVS is an american retailer and drugstore chain spread in the USA.]
BalkansCat

* CVS Health (NYSE:CVS [https://seekingalpha.com/symbol/CVS]) shares are down ~4% in Monday afternoon trading following a presentation by top executives at the Morgan Stanley Global Healthcare Conference.
* The presentation didn't include any updated financial guidance or commentary on the upcoming release from the federal government on star ratings for Medicare Advantage plans. The ratings come out in the fall.
* CEO David Joyner and CFO Brian Newman presented at the conference, _Bloomberg_ reported [https://www.bloomberg.com/news/articles/2025-09-08/cvs-drops-on-investor-worries-about-government-quality-ratings].
* One of the two execs, aware of the stock drop during the presentation, said later that CVS has a policy of not providing updated guidance between quarterly earnings releases.
* Star ratings are important for companies offering Medicare Advantage plans as they indicate the quality and performance of each plan. The more stars, the more highly regarded the plan is, which can impact customer selection.
* CVS offers MA plans through its Aetna subsidiary. The company has previously said [https://seekingalpha.com/pr/19876553-aetna-shines-in-star-ratings-with-88-percent-of-medicare-advantage-members-in-4-star-plans-or] that for 2025, 88% of its MA members were in plans rated 4-stars or higher.

MORE ON CVS

* CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead [https://seekingalpha.com/article/4814525-cvs-health-outlier-in-healthcare-implosion-further-margin-recovery-ahead]
* CVS Health: Health Insurers Get Buffett's Stamp Of Approval (Rating Upgrade) [https://seekingalpha.com/article/4814257-cvs-health-health-insurers-get-buffett-stamp-of-approval-rating-upgrade]
* CVS Health Corporation 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4809738-cvs-health-corporation-2025-q2-results-earnings-call-presentation]
* CVS Caremark facing class action suit for dropping coverage of Lilly's Zepbound [https://seekingalpha.com/news/4492800-cvs-caremark-facing-class-action-suit-dropping-coverage-lilly-zepbound]
* House lawmakers probe CVS over bill lobbying in Louisiana [https://seekingalpha.com/news/4492420-house-lawmakers-probe-cvs-over-bill-lobbying-in-louisiana]